About Us
Veritas Intercontinental operates in Europe, Latin America, Japan and the United Arab Emirates. Its mission is to promote whole genome sequencing and provide information to people, that empowers them to maximize their and their families' quality and duration of life, while changing the way the world views genetics.
Veritas was the first company to offer full-scale whole genome sequencing and interpretation, and with its physicians leads the field of genetics, pushing the boundaries of science using innovative technology, while reducing the cost of whole genome sequencing.
Veritas was founded in 2014 by leaders in genomics from Harvard Medical School and operates all around world from offices based in the United States, Europe and China. The company was recognized by MIT Technology Review as one of the 50 Smartest Companies in 2016 and 2017, by Fast Company as one of the most innovative health companies in the world in 2018, and by CNBC as one of the Disruptor 50 companies in 2018 and 2019.
In 2018, a noted group of experts in genetics founded Veritas Intercontinental, expanding Veritas technology to the international market and developing new products, essential in personalized precision medicine.
Press releases
Graham Snudden Joins the Veritas Intercontinental Board of Directors
Snudden was a co-founder of BlueGnome Ltd, a spin-out from the University of Cambridge, whose 24sure technology became the standard in... read more
28.05.2020 • By VERITAS INTERCONTINENTAL
